Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 3, 2006, Pages 1033-1043

  Mukhin, Yurii V ^b   Gooz, Monika ^b   Raymond, John R ^b   Garnovskaya, Maria N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BATIMASTAT; BRADYKININ B2 RECEPTOR; COLLAGENASE; COLLAGENASE 2; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; GM 1489; ILOMASTAT; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; NEUTROPHIL COLLAGENASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; SMALL INTERFERING RNA; STROMELYSIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSFECTION; KIDNEY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

ANIMALS; BRADYKININ; CALCIUM; CELLS, CULTURED; COLLAGENASES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; KIDNEY TUBULES, COLLECTING; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 8; MICE; PHOSPHORYLATION; RECEPTOR, BRADYKININ B2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33747593550     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104000     Document Type: Article

References (40)

1. 2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol 19:5289-5297.
2. Bae SS, Choi JH, Oh YS, Perry DK, Ruy SH, and Suh PG (2001) Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett 491:16-20.
3. Bernier SG, Haldar S, and Michel T (2000) Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 275:30707-30715.
4. Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, and Baselga J (1999) Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. Cancer Res 59:1196-1201.
5. Dikic I, Tokiwa G, Lev S, Courtneidge SA, and Schlessinger J (1996) A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (Lond) 383:547-550.
6. 2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist. Br J Pharmacol 131:1553-1560.
7. Egeblad M and Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
8. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T (2001) Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276:7957-7962.
9. El-Dahr SS, Dipp S, and Baricos WH (1998) Bradykinin stimulates the ERK-Elk-1-Fos/AP-1 pathway in mesangial cells. Am J Physiol 275:F343-F352.
10. i coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296:426-433.
11. Graness A, Hanke S, Boehmer FD, Presek P, and Liebmann C (2000) Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transin-activation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem J 347:441-447.
12. Grosse R, Roelle S, Herrlich A, Hohn J, and Gudermann T (2000) Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone. J Biol Chem 275:12251-12260.
13. Gschwind A, Zwick E, Prenzel N, Leserer M, and Ullrich A (2001) Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594-1600.
14. Harris RC, Chung E, and Coffey RJ (2003) EGF receptor ligands. Exp Cell Res 284:2-13.
15. He C, Zalups RK, Henderson DA, Striker GE, and Striker LJ (1995) Molecular analysis of spontaneous glomerulosclerosis in Os/+ mice, a model with reduced nephron mass. Am J Physiol 269:F266-F273.
16. Jaffa AA, Miller BS, Rosenzweig SA, Naidu PS, Velarde V, and Mayfield RK (1997) Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol 273:F916-F924.
17. Junttila TT, Sundvall M, Maatta JA, and Elenius K (2000) ErbB4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10:304-310.
18. Kalmes A, Vesti BR, Daum G, Abraham JA, and Clowes AW (2000) Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87:92-98.
19. Kanwar YS, Ota K, Yang Q, Wada J, Kashihara N, Tian Y, and Wallner EI (1999) Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. Am J Physiol 277:F934-F947.
20. 2+, PYK-2, and p60src. J Biol Chem 275:12619-12625.
21. 2 receptor in the follicles of porcine ovary and increased expression of matrix metalloproteinase-3 and -20 in cultured granulosa cells by bradykinin treatment. Biol Reprod 65:1462-1470.
22. Lal MA, Proulx PR, and Hebert RL (1998) A role for PKC epsilon and MAP kinase in bradykinin-induced arachidonic acid release in rabbit CCD cells. Am J Physiol 274:F728-F735.
23. Lelongt B and Ronco P (2002) Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. Nephrol Dial Transplant 17 (Suppl 9):28-31.
24. Lenz O, Elliot SJ, and Stetler-Stevenson WG (2000) Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11:574-581.
25. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, Daaka Y, Lefkowitz RJ, and Luttrell LM (2000) The β2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275:9572-9580.
26. McCole DF, Keely SJ, Coffey RJ, and Barrett KE (2002) Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-α. J Biol Chem 277:42603-42612.
27. Mifune M, Ohtsu H, Suzuki H, Nakashima H, Brailoiu E, Dun NJ, Frank GD, Inagami T, Higashiyama S, Thomas WG, et al. (2005) G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 280:26592-26599.
28. 2 receptor activates extracellular signal-regulated protein kinase in mIMCD-3 cells via epidermal growth factor receptor transactivation. J Pharmacol Exp Ther 304:968-977.
29. 2+/calmodulin. J Biol Chem 276:17339-17346.
30. Nagase H and Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494.
31. Norman JT and Lewis MP (1996) Matrix metalloproteinases (MMPs) in renal fibrosis. Kidney Int Suppl 54:S61-S63.
32. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (Lond) 402:884-888.
33. Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, and Gudermann T (2003) Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem 278:47307-47318.
34. 2 receptor activation. Thromb Haemostasis 89:735-740.
35. 2 receptor activation reduces renal fibrosis. J Clin Investig 110:371-379.
36. Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, and Catt KJ (2004) Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Mol Endocrinol 18:2035-2048.
37. Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Murasawa S, Mori Y, Kosaki A, Maruyama K, Masaki H, Shibasaki Y, Fujiyama S, et al. (2001) Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int 60:2153-2163.
38. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, and Jaffa AA (1999) Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol 277:C253-C261.
39. Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Goodling WE, and Grandis JR (2004) Src family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Res 64:6166-6173.
40. Zhao D, Zhan Y, Koon HW, Zeng H, Keates S, Moyer MP, and Pothoulakis C (2004) Metalloproteinase-dependent transforming growth factor-α release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem 279:43547-43554.